McKesson Pharmaceutical Revenue and Competitors
Estimated Revenue & Valuation
- McKesson Pharmaceutical's estimated annual revenue is currently $14.4M per year.
- McKesson Pharmaceutical's estimated revenue per employee is $145,000
Employee Data
- McKesson Pharmaceutical has 99 Employees.
- McKesson Pharmaceutical grew their employee count by 5% last year.
McKesson Pharmaceutical's People
Name | Title | Email/Phone |
---|
McKesson Pharmaceutical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.7M | 67 | 14% | N/A | N/A |
#2 | $27.3M | 175 | -3% | $10M | N/A |
#3 | $265.1M | 1306 | -16% | N/A | N/A |
#4 | $8.9M | 68 | -8% | N/A | N/A |
#5 | $28.4M | 178 | -12% | N/A | N/A |
#6 | $5M | 45 | 13% | $16.8M | N/A |
#7 | $36.2M | 227 | -8% | N/A | N/A |
#8 | $19.7M | 136 | 5% | N/A | N/A |
#9 | $12.9M | 89 | 5% | $7M | N/A |
#10 | $231M | 1138 | 9% | N/A | N/A |
What Is McKesson Pharmaceutical?
McKesson Pharmaceutical is a Computer Software company located in 1515 W Bella Vista St, Lakeland, Florida, United States.
keywords:N/AN/A
Total Funding
99
Number of Employees
$14.4M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
McKesson Pharmaceutical News
2022-04-20 - Alabama settles for $276M with McKesson, J&J and Endo ...
... Endo Pharmaceuticals and McKesson for about $276 million to resolve the state's claims against them for exacerbating the opioid crisis.
2022-04-17 - Alabama settles opioid claims with J&J, McKesson, Endo for ...
Under the settlement, drug distributor McKesson will pay $141 million toward the state's efforts to combat the opioid crisis,...
2022-04-17 - J&J, Endo and McKesson settle Alabama opioid litigation for ...
But the pharma giant isn't stopping there. As part of a new state-specific settlement, Alabama's attorney general Steve Marshall said the state will collect...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15.3M | 102 | 38% | N/A |
#2 | $15.3M | 102 | 38% | N/A |
#3 | $21.8M | 104 | 9% | N/A |
#4 | $26.1M | 104 | 21% | N/A |
#5 | $36.6M | 111 | 5% | N/A |